These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36789657)

  • 1. Comparison of treatment strategies for resectable locally advanced primary mucinous adenocarcinoma of the lung.
    Gu Y; Zhu H; Deng J; Zhang J; Chen T; Lai S
    Cancer Med; 2023 Apr; 12(8):9303-9312. PubMed ID: 36789657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma.
    Chen Z; Li M; Ma K; Shang G; Liang J; Yin J; Luo J; Zhan C; Shi Y; Wang Q
    Cancer Med; 2020 Jan; 9(2):517-529. PubMed ID: 31769218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
    Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
    Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival benefit of surgery with postoperative radiotherapy in locally advanced cervical adenocarcinoma: a population-based analysis.
    Wang X; Lu X; Chen J; Yi H; Lan Q
    BMC Surg; 2023 Oct; 23(1):299. PubMed ID: 37789291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study.
    Zeng WQ; Feng W; Xie L; Zhang CC; Yu W; Cai XW; Fu XL
    Lung; 2019 Dec; 197(6):741-751. PubMed ID: 31705271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer.
    Yuan C; Tao X; Zheng D; Pan Y; Ye T; Hu H; Xiang J; Zhang Y; Chen H; Sun Y
    J Surg Oncol; 2019 Mar; 119(3):379-387. PubMed ID: 30536966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Log odds of positive lymph nodes is a robust predictor of survival and benefits from postoperative radiotherapy in stage IIIA-N2 resected non-small cell lung cancer.
    Jin X; Chen D; Shen Y; Shu J; Sang Y; Yang W; Duan S; Chen Y
    Thorac Cancer; 2022 Oct; 13(19):2767-2775. PubMed ID: 36054738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Postoperative or Preoperative Radiotherapy on Prognosis in Patients with Stage II Resectable Non-Small Cell Lung Cancer: A Retrospective Study Based on the SEER Database.
    Chen D; Yu J
    Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833420
    [No Abstract]   [Full Text] [Related]  

  • 10. Patients with Lower Positive Lymph Nodes Ratio May Benefit from Preoperative Radiotherapy in Stage III Non-Small Cell Lung Cancer.
    Wang R; Shang S; Huang X; Nie Y; Wang F; Yu J; Chen D
    Technol Cancer Res Treat; 2023; 22():15330338231173498. PubMed ID: 37157831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative radiotherapy improves survival of patients with ypN2 non-small cell lung cancer after neoadjuvant chemotherapy followed by surgery - A propensity score matching study of the Surveillance, Epidemiology, and End Results database.
    Bao Y; Yang X; Men Y; Kang J; Sun X; Zhao M; Sun S; Yuan M; Ma Z; Hui Z
    Thorac Cancer; 2022 Feb; 13(3):404-411. PubMed ID: 34907665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative survival of pulmonary invasive mucinous adenocarcinoma versus non-mucinous invasive adenocarcinoma.
    Cui D; Xie S; Liu Q
    BMC Pulm Med; 2023 Jan; 23(1):9. PubMed ID: 36624430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival Patterns for Patients with Resected N2 Non-Small Cell Lung Cancer and Postoperative Radiotherapy: A Prognostic Scoring Model and Heat Map Approach.
    Deng W; Xu T; Xu Y; Wang Y; Liu X; Zhao Y; Yang P; Liao Z
    J Thorac Oncol; 2018 Dec; 13(12):1968-1974. PubMed ID: 30194035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative radiotherapy for pathological stage IIIA-N2 non-small cell lung cancer with positive surgical margins.
    Yuan M; Men Y; Kang J; Sun X; Zhao M; Bao Y; Yang X; Sun S; Ma Z; Wang J; Deng L; Wang W; Zhai Y; Liu W; Zhang T; Wang X; Bi N; Lv J; Liang J; Feng Q; Chen D; Xiao Z; Zhou Z; Wang L; Hui Z
    Thorac Cancer; 2021 Jan; 12(2):227-234. PubMed ID: 33247556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.
    Urban D; Bar J; Solomon B; Ball D
    J Thorac Oncol; 2013 Jul; 8(7):940-6. PubMed ID: 23695418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.
    Mikell JL; Gillespie TW; Hall WA; Nickleach DC; Liu Y; Lipscomb J; Ramalingam SS; Rajpara RS; Force SD; Fernandez FG; Owonikoko TK; Pillai RN; Khuri FR; Curran WJ; Higgins KA
    J Thorac Oncol; 2015 Mar; 10(3):462-71. PubMed ID: 25384064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of postoperative radiotherapy on the survival of patients with stage III non-small cell lung cancer: A CONSORT-compliant analysis using the SEER database.
    Wu K; Peng W; Shuai Z; Peng X; Liu H; Zhang S
    Medicine (Baltimore); 2023 Jun; 102(24):e34015. PubMed ID: 37327271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy.
    Yang H; Wang K; Li S; Li Y; Yuan L
    Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289
    [No Abstract]   [Full Text] [Related]  

  • 19. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.
    Lally BE; Zelterman D; Colasanto JM; Haffty BG; Detterbeck FC; Wilson LD
    J Clin Oncol; 2006 Jul; 24(19):2998-3006. PubMed ID: 16769986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Postoperative Radiotherapy Effect on Survival of Resected Stage III-N2 Non-small Cell Lung Cancer Patients.
    Gao F; Li N; Xu Y; Yang G
    Front Oncol; 2020; 10():1135. PubMed ID: 32850322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.